PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin Therapy
PHASE3CompletedINTERVENTIONAL
Enrollment
600
Participants
Timeline
Start Date
Not specified
Conditions
Chronic Hepatitis C Virus Infection
Interventions
DRUG
PEGIntron plus ribavirin
Trial Locations (1)
21287
Johns Hopkins Univesity School of Medicine, Baltimore
All Listed Sponsors
collaborator
Hoffmann-La Roche
INDUSTRY
lead
Hepatitis Resource Network
OTHER
NCT00215865 - PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin Therapy | Biotech Hunter | Biotech Hunter